Pfizer denies Gain of Function, Directed Evolution claim!

In response to the viral Project Veritas video, Pfizer has publicly denied conducting any Gain of Function, or Directed Evolution research in developing their COVID-19 vaccine!

Take a look at the viral claim, and find out what the facts really are!

Is Pfizer Mutating COVID-19 Virus Using Gain of Function / Directed Evolution?!

Project Veritas recently released a viral “sting” video involving Jordon Trishton Walker, who was identified as the Pfizer Director of Research and Development Strategic Operations and mRNA Scientific Planning.

In that viral video, short clips were edited to show Jordon Trishton Walker telling a Project Veritas journalist that Pfizer is mutating the COVID-19 virus to continue profiting from vaccines!

Project Veritas also edited their blurbs to make it sound like Jordon was admitting that the COVID-19 virus was created in Wuhan, China.

BREAKING: @Pfizer Exploring “Mutating” COVID-19 Virus For New Vaccines

“Don’t tell anyone this… There is a risk… have to be very controlled to make sure this virus you mutate doesn’t create something… the way that the virus started in Wuhan, to be honest”.

Recommended : Died Suddenly : Anti-Vaccination Movie Lies Exposed!

 

Pfizer Denies Gain of Function, Directed Evolution Claims!

At 8 PM on Friday, January 27, 2023, Pfizer issued a public statement to address the gain of function and directed evolution claims made in the Project Veritas video.

The statement did not address whether Jordon Trishton Walker is a Pfizer employee, or a consultant on secondment from the Boston Consulting Group.

Instead, the statement directly refutes the allegations that Pfizer conducted gain of function, or directed evolution research in developing its COVID-19 vaccine. Here is a quick summary of what Pfizer said:

Research Involving Pfizer-BioNTech COVID-19 Vaccine

  • Pfizer has not conducted gain of function research in the ongoing development of its COVID-19 vaccine.
  • Pfizer has not conducted directed evolution research in the ongoing development of its COVID-19 vaccine.
  • Working with partners (like BioNTech), Pfizer has modified the original SARS-CoV-2 virus so it produces the spike protein from new variants of concern that have been identified by public health authorities, to test their immune escape potential against antibodies produced by its COVID-19 vaccine antibodies.

This matches up with what Jordon Trishton Walker actually said in the viral Project Veritas video – Pfizer did not actually conduct any gain-of-function, or directed evolution research.

… it was a thought that came up in a meeting and we were like, why do we not — it was like, we’re going to consider that with more discussions.

Recommended : Did Study Show Pfizer Vaccine Altering Liver DNA In 6 Hours?!

Research Involving Pfizer PAXLOVID

  • Pfizer has also performed laboratory (in vitro) work to identify potential mutations that can cause resistance to nirmatrelvir – one of the two antiviral components in its PAXLOVID oral treatment for COVID-19.
  • Most of this work was conducted using computer simulations, or mutations of the main protease – an enzyme the virus uses to breaks down proteins.
  • However, Pfizer may engineer the SARS-CoV-2 virus to allow the assessment of antiviral activity in cells.
  • These in vitro resistance selection experiments are conducted in cells incubated with the SARS-CoV-2 virus and nirmatrelvir in a secure Biosafety Level 3 (BSL3) laboratory, to assess whether the main protease enzyme can mutate to become resistant to nirmatrelvir.

Pfizer appears to be admitting that it does engineer the COVID-19 virus, but clarifying that it was not done to create new vaccines. Rather, such research is being done to determine if PAXLOVID may potentially fail to work against a new variant.

Pfizer does not state whether they are engineering SARS-CoV-2 through gain-of-function or directed evolution, but such research is being conducted to determine whether the virus can mutate to become resistant to nirmatrelvir, which is the new protease inhibitor they developed.

However, as I pointed out in my earlier article, Pfizer does not actually need to perform such research to develop new COVID-19 vaccines using mRNA technology.

Read more : Did Project Veritas Show Pfizer Mutating COVID-19?!

 

Official Pfizer Statement On Gain of Function, Directed Evolution Claims

Here is the official Pfizer statement on the gain of function and directed evolution claims made in the Project Veritas video.

New York, N.Y., January 27, 2023 – Allegations have recently been made related to gain of function and directed evolution research at Pfizer and the company would like to set the record straight.

In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research. Working with collaborators, we have conducted research where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern. This work is undertaken once a new variant of concern has been identified by public health authorities. This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. We then make this data available through peer reviewed scientific journals and use it as one of the steps to determine whether a vaccine update is required.

In addition, to meet U.S. and global regulatory requirements for our oral treatment, PAXLOVID™, Pfizer undertakes in vitro work (e.g., in a laboratory culture dish) to identify potential resistance mutations to nirmatrelvir, one of PAXLOVID’s two components. With a naturally evolving virus, it is important to routinely assess the activity of an antiviral. Most of this work is conducted using computer simulations or mutations of the main protease–a non-infectious part of the virus. In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus. It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.

Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease.

 

Please Support My Work!

Support my work through a bank transfer /  PayPal / credit card!

Name : Adrian Wong
Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp

Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.

He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.

 

Recommended Reading

Go Back To > Fact Check | HealthTech ARP

 

Support Tech ARP!

Please support us by visiting our sponsors, participating in the Tech ARP Forums, or donating to our fund. Thank you!

Leave a ReplyCancel reply